ONCT

Oncternal Therapeutics, Inc. Common Stock
ONCT

Overview Fund Activity
Delisted

ONCT was delisted on the 2nd of December, 2024.

Back to rankings

23 hedge funds and large institutions have $7.68M invested in Oncternal Therapeutics, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 5 closing their positions.

Holders
23
Holders Change
-2
Holders Change %
-8%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AC
1
Armistice Capital
New York
$3.57M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$193K
3
BlackRock
3
BlackRock
New York
$185K
4
Morgan Stanley
4
Morgan Stanley
New York
$61K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$54K

Top Sellers

1
Victory Capital Management
1
Victory Capital Management
Texas
$0
2
Millennium Management
2
Millennium Management
New York
$178K
3
MAM
3
Meeder Asset Management
Ohio
$6K
4
State Street
4
State Street
Massachusetts
$61K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$808K
Name Market Value Shares Shares
Change 		Shares
Change %
CFGS
26
Concourse Financial Group Securities
Alabama
– – – –
Wells Fargo
27
Wells Fargo
California
$0 61 – –
BBHC
28
Brown Brothers Harriman & Co
New York
$0 2 +2 New
JPMorgan Chase & Co
29
JPMorgan Chase & Co
New York
$0 7 +7 New
1
2